This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Everest Re (RE) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
Everest Re's (RE) Q3 results are likely to benefit from rate increases, strong renewal retention, new business, and higher net investment income, offset by higher cat loss.
What's in the Cards for Willis Towers (WLTW) in Q3 Earnings?
by Zacks Equity Research
Willis Towers (WLTW) third-quarter results are likely to reflect the impact of higher talent and rewards revenues, higher demand for advisory services across various lines of business, and new business wins across multiple lines.
What's in Store for Cincinnati Financial's (CINF) Q3 Earnings?
by Zacks Equity Research
Cincinnati Financial's (CINF) third-quarter results are likely to reflect higher premiums, new business growth and rate increases across business lines, partly offset by higher underwriting costs.
Aflac (AFL) to Report Q3 Earnings: Is a Beat in the Cards?
by Zacks Equity Research
Aflac's (AFL) Q3 results are likely to reflect a decline in earnings as well as revenues.
Chubb (CB) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Chubb (CB) Q3 earnings likely to reflect impact of positive rate increases, exposure growth, strong renewal retention, and growth in new business written partially offset by cat loss.
What's in the Cards for W. R. Berkley (WRB) in Q3 Earnings?
by Zacks Equity Research
W. R. Berkley's (WRB) third-quarter results are likely to reflect premium growth and improved expense ratio, partly offset by higher expenses and lower underwriting income.
7 Insurers Poised to Outperform Q3 Earnings Expectation
by Tanuka De
Better pricing, exposure growth, redesigning of products and sturdy capital are expected to help WRB, ATH, MET, PRI, CI, AJG, and AFL outperform Q3 earnings estimates.
Here's How Investors Can Find Strong Finance Stocks with the Zacks ESP Screener
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Aflac (AFL) Rides on Strength at U.S and Japan Segments
by Zacks Equity Research
Aflac (AFL) is well poised for growth on the back of a rebound in top-line growth and other strategic measures
What's in the Cards for Marsh & McLennan (MMC) Q3 Earnings?
by Zacks Equity Research
Marsh & McLennan's (MMC) third-quarter results are likely to reflect better revenues and a solid contribution from its Risk and Insurance Services segment.
Will MetLife (MET) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
MetLife (MET) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Prudential (PRU) Establishes Retirement Strategies Business
by Zacks Equity Research
Prudential's (PRU) Prudential Retirement Strategies bring together Individual Annuities business and Retirement Institutional Investment Products.
Reasons Why Investors Should Retain EverQuote (EVER) Stock
by Zacks Equity Research
EverQuote (EVER) is poised to benefit from improvements in traffic volumes and monetization, improved performance of automotive insurance providers and robust capital position.
MetLife (MET) Ups Stake in PNB Metlife to Boost India Presence
by Zacks Equity Research
MetLife (MET) inks deal to purchase combined stake of IGE and Elpro in PNB MetLife. With increased stake in India's JV, the company intends to bolster its presence in India.
Zacks.com featured highlights include: Academy Sports and Outdoors, M/I Homes, MetLife, ArcelorMittal and Nu Skin Enterprises
by Zacks Equity Research
Zacks.com featured highlights include: Academy Sports and Outdoors, M/I Homes, MetLife, ArcelorMittal and Nu Skin Enterprises
MET or PUK: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
MET vs. PUK: Which Stock Is the Better Value Option?
7 Low Price-to-Sales Stocks for Value-Focused Investors
by Rajani Lohia
Price-to-sales is a convenient tool to gauge the value of stocks that are incurring losses or are in an early development cycle. Stocks like SIG, GIII, NUS, MET, MT, MOS and HIBB are promising picks.
Pick These 5 Bargain Stocks With Alluring EV-to-EBITDA Ratios
by Anindya Barman
We have screened bargain stocks ASO, MHO, MET, MT and NUS based on EV-to-EBITDA ratio that offers a clearer picture of valuation and earnings potential.
Top 5 Financial Stocks to Tap Higher Government Bond Yields
by Nalak Das
We have narrowed down our search to five large-cap insurers that have strong growth potential for the rest of 2021. These are: AFL, AFG, MET, FNF and MKL.
MetLife (MET) Arm Ties Up to Boost Digital Suite in Bangladesh
by Zacks Equity Research
MetLife's (MET) unit MetLife Bangladesh joins forces with Citi to offer a H2H payment processing platform to help customers make online premium payments.
Is MetLife (MET) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Assurant (AIZ) Gains 17% YTD: Can It Retain the Momentum?
by Zacks Equity Research
Strong performing Global Lifestyle business, growing the fee-based capital-light businesses and solid capital management continue to drive Assurant (AIZ).
MET vs. PUK: Which Stock Is the Better Value Option?
by Zacks Equity Research
MET vs. PUK: Which Stock Is the Better Value Option?
3 Value Picks From the Undervalued Multiline Insurance Space
by Tanuka De
Leveraging solid fundamentals and adopting technological advancements to increase operational efficiency amid optimistic economic growth outlook, undervalued multiline insurers MET, HIG, ORI are poised to fetch better return.
7 Low Price-to-Sales Stocks to Buy in the Current Market
by Rajani Lohia
Price-to-sales is a convenient tool to gauge the value of stocks that are incurring losses or are in an early development cycle. Stocks like FL, GIII, NUS, MET, PIPR, HIBB, and SMP are promising picks.